Patent application number | Description | Published |
20100093697 | Substituted Imidazopyridine Derivatives As Melanocortin-4 Receptor Antagonists - The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin-4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amytrophic lateral sclerosis (ALS), anxiety and depression. | 04-15-2010 |
20100249093 | Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators - The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention. | 09-30-2010 |
20100324036 | SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR ANTAGONISTS - The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin 4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cachexia induced by e.g. cancer, chronic kidney disease (CKD) or chronic heart failure (CHF), muscle wasting, anorexia induced by e.g. chemotherapy or radiotherapy, anorexia nervosa, amyotrophic lateral sclerosis (ALS), pain, neuropathic pain, anxiety and depression. | 12-23-2010 |
20110086836 | Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators - The present invention relates to substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention. | 04-14-2011 |
Patent application number | Description | Published |
20090176123 | Metallized Shrinkable Label - The present invention is a metallized shrinkable label and a method for producing the same. The label of the invention is composed of a shrinkable film base and a graphic. The graphic is created by combining pigmented inks, a metallic coating and a shrink-resistant coating which is printed in a predetermined pattern with gaps so that upon exposure of the label to heat, the gaps close thereby forming a continuous graphic layer Advantageously, the shrink-resistant coating minimizes discoloration and pleating of the metallic coating. | 07-09-2009 |
20110155606 | Scented Label - The present invention embraces a scented label and methods of producing and using the same. The label of the invention is composed of a base layer, a scented thermoplastic layer, and a removable protective barrier layer which blocks release of the scent from the thermoplastic layer until desired by a consumer. | 06-30-2011 |
20120255884 | Label with Detachable Voltage Indicator and Battery Package Containing the Same - The present invention provides an adhesive label in which a consumer item or device, such as a battery tester strip is printed in web form and is bonded to a consumer package. | 10-11-2012 |
20130193976 | LABEL WITH ON-BATTERY VOLTAGE INDICATOR - The present invention is a shrink label with a die cut voltage indicator device integrated therewith. | 08-01-2013 |
20130312302 | Metallized Shrinkable Label - The present invention is a metallized shrinkable label and a method for producing the same. The label of the invention is composed of a shrinkable film base and a graphic. The graphic is created by combining pigmented inks, a metallic coating and a shrink-resistant coating which is printed in a predetermined pattern with gaps so that upon exposure of the label to heat, the gaps close thereby forming a continuous graphic layer. Advantageously, the shrink-resistant coating minimizes discoloration and pleating of the metallic coating. | 11-28-2013 |
20140002874 | Holographic Structure and Method for Producing the Same | 01-02-2014 |
20140054193 | Unidirectional Oriented Polyethylene-Based Heat Shrinkable Polymeric Label - The present invention features pressure-sensitive labels produced from unidirectional heat shrinkable polyethylene films and their application to consumer products such as containers, tubes, bottles and batteries. | 02-27-2014 |
20150013273 | Expanded Content Heat Shrinkable Label - The present invention is tamper evident shrinkable label with expanded content. The label comprises a label formed from a film having first and second ends, an adhesive coating on a backside of the label for attachment to a consumer product, an expanded content panel at least partly defined by the first end of the label and extending past the second end of the label on a consumer product, and a release coating on a front side of the label positioned opposite to releasably adhere to the backside of the expanded content panel on a consumer product. | 01-15-2015 |